Pulmonx Corporation provided revenue guidance for the full year 2022. The company continues to expect revenue for the full year 2022 to be in the range of $55 million to $60 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 USD | -3.97% | -5.45% | -48.31% |
Jun. 04 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.31% | 264M | |
-24.80% | 7.29B | |
+6.40% | 6.75B | |
+18.57% | 5.5B | |
-18.64% | 4.75B | |
+18.17% | 4.1B | |
-20.73% | 3.93B | |
-26.70% | 2.7B | |
+43.67% | 2.31B | |
+1.86% | 2.06B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Full Year 2022